Idiopathic polypoidal choroidal vasculopathy

Search with Google Search with Bing
Information
Disease name
Idiopathic polypoidal choroidal vasculopathy
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02397954 Completed Phase 2 A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) March 2015 October 2015
NCT03374670 Withdrawn Phase 2 ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) November 2018 December 2019
MedGen concept unique identifier (MedGen Concept name)
C0730364
MedGen unique identifier (MedGen Concept name)
676553